Inhibiting FANCM-TOP3A-RMI1 interaction for osteosarcoma, Lesch-Nyhan syndrome

DISEASE CATEGORY: Cancer; endocrine/metabolic

INDICATION: Bone cancer; metabolic

Cell culture studies suggest inhibiting the FANCM-TOP3A-RMI1 interaction

Read the full 144 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE